Track topics on Twitter Track topics that are important to you
Quest Diagnostics has introduced three new cancer test services, which will enable clinicians to predict the development of hereditary forms of cancer in individuals.
Louisville startup Breath Diagnostics has developed technology to pick up cancer-related compounds that are exhaled in one’s breath.
Breast Cancer Index & CancerTYPE ID Tests Provide Patient-Specific Information to Aid in Treatment Decisions with the Goal of Improving Outcomes SAN DIEGO & PALO ALTO, Calif.–(BUSINESS W...
AccuraGen Holdings, a US-China cancer diagnostics company, has closed a $40 million Series B financing. AccuraGen develops blood tests that sequence cell free DNA (cfDNA) to provide sensitive and accu...
Thursday, September 22nd 2016 at 5:18pm UTC Breast Cancer Index & CancerTYPE ID Tests Provide Patient-Specific Information to Aid in Treatment Decisions with the Goal of Improving Outcomes SAN DIE...
Cernostics, a Pittsburgh, PA-based cancer diagnostics startup has raised $5 million in funding led by UPMC Enterprises, UPMC’s venture capital arm with participation from Novitas Capital. The co...
Aberdeen, we say goodbye to you! We’re leaving Scotland this week and are heading down to Belgium. Besides being the place where most of the European Union action happens, Belgium also has a st...
Interpace Diagnostics Group has introduced a new version of its AccuCEA product dubbed Insights for pancreatic cancer testing.
The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.
Single-cell proteomics in cancer is evolving and promises to provide more accurate diagnoses based on detailed molecular features of cells within tumors. This review focuses on technologies that allow...
Companion diagnostics (CDx) have become a major tool in molecular pathology and assist in therapy decisions in an increasing number of various cancers. Particularly, the developments in lung cancer ha...
This commentary highlights the article by Misyura et al that underscores the use of next-generation sequencing platforms for detection and verification of somatic variants.
Early diagnostics of colorectal cancer is complicated by the lack of reliable serum biomarkers. This study aimed to investigate if the serum level of activin A can be used for diagnostics of this dise...